- Pristine Surgical and NexOptic (NXO) have entered into a commercial agreement to use artificial intelligence for single-use surgical endoscopy
- NexOptic will deploy its AI-powered imaging technology in Pristine’s single-use endoscopic visualization platform
- Pristine Surgical is a single-use surgical visualization company dedicated to improving patient care during endoscopic procedures
- NexOptic offers an AI-powered imaging platform known as ALIIS, or All Light Intelligent Imaging Solutions
- NexOptic (NXO) is up 28.57 per cent and is currently trading at C$0.54 per share
Pristine Surgical and NexOptic (NXO) have entered into a commercial agreement to use artificial intelligence for single-use surgical endoscopy.
NexOptic will deploy its AI-powered imaging technology in Pristine’s single-use endoscopic visualization platform.
NexOptic’s proprietary neural networks are machine-learning-enabled and allow for lower-cost, lightweight optics with extreme low-light, anti-glare and data compression performance.
Pristine Surgical’s single-use endoscopes use high-performance digital sensors, high-brightness LEDs and graphics-processing hardware and software to deliver high-definition images at reduced cost.
Bryan Lord, CEO of Pristine Surgical, commented,
“At Pristine, we are able to increase patient safety, improve economics and efficiency and advance the state of the art in endoscopy by incorporating powerful, cutting-edge technologies in a single-use visualization platform.
We’re excited to work with NexOptic to use their ALIIS platform to advance our deployment of artificial intelligence capabilities and help us further that mission.”
Paul McKenzie, CEO of NexOptic Technologies, added,
“Pristine has built the endoscopy platform of the future. By combining our AI expertise with their unique single-use scope design, there’s an immediate opportunity to further advance the surgical visualization platform of tomorrow.
Today’s announcement is a milestone for NexOptic’s artificial intelligence imaging solutions. I look forward to the future and fully anticipate signing additional clients this year.”
Pristine Surgical is a single-use surgical visualization company dedicated to improving patient care, safety and efficacy for the more than 25 million endoscopic procedures performed each year.
NexOptic offers an AI-powered imaging platform known as ALIIS, or All Light Intelligent Imaging Solutions.
NexOptic (NXO) is up 28.57 per cent and is currently trading at C$0.54 per share as of 11:04 am ET.